Webull Financial is a leading online brokerage platform committed to empowering self-directed investors with innovative tools and cutting-edge technology. With low-cost trading on a wide range of ...

Webull Financial is a leading online brokerage platform committed to empowering self-directed investors with innovative tools and cutting-edge technology. With low-cost trading on a wide range of ...

MIAMI--(BUSINESS WIRE)--ShiftPixy, Inc. (Nasdaq: PIXY) (“ShiftPixy” or the “Company”), a Florida-based national human capital provisioning enterprise which designs, manages, and sells access to a ...

Activated T cells play an important role in the inflammatory process. Foralumab, the only fully human anti-CD3 monoclonal antibody (mAb), binds to the T cell receptor and dampens inflammation by ...

Trent Ward (CEO) to present on Wednesday, October 18 th at 3:00PM/ET FORME is a digital fitness platform that combines premium smart home gyms with live virtual personal training and coaching to ...

Webull delivered one of its strongest quarters since going public — revenue accelerated to 55% YoY, trading-related revenue surged 64%, and the company posted $36.7M in adjusted operating profit, a ...

Mean Target Price: $18.50 Median Target Price: $18.50 High/Low Range: $19.00 / $18.00 Number of Analysts: 2 Rating: Buy (1.00) — the strongest rating on the scale Analysts covering BULL see the stock ...

This content is provided by an external author without editing by Finextra. It expresses the views and opinions of the author. Through licensed financial services trading firm Webull Securities ...

Webull Financial is a leading online brokerage platform committed to empowering self-directed investors with innovative tools and cutting-edge technology. With low-cost trading on a wide range of ...

Webull Financial is a leading online brokerage platform committed to empowering self-directed investors with innovative tools and cutting-edge technology. With low-cost trading on a wide range of ...

NEW YORK, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel ...

Akari Therapeutics is an oncology biotechnology company developing next-generation spliceosome payload antibody drug conjugates (ADCs). Utilizing its innovative ADC discovery platform, the Company has ...